CN102939542B - 用于泌尿道感染的分子标记物 - Google Patents

用于泌尿道感染的分子标记物 Download PDF

Info

Publication number
CN102939542B
CN102939542B CN201180014501.XA CN201180014501A CN102939542B CN 102939542 B CN102939542 B CN 102939542B CN 201180014501 A CN201180014501 A CN 201180014501A CN 102939542 B CN102939542 B CN 102939542B
Authority
CN
China
Prior art keywords
procalcitonin
application
urine
concentration
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180014501.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN102939542A (zh
Inventor
弗朗切斯科·琼塔
弗朗切斯科·福尔弗里
加达·瑟里
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita di Pisa
Original Assignee
Universita di Pisa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita di Pisa filed Critical Universita di Pisa
Publication of CN102939542A publication Critical patent/CN102939542A/zh
Application granted granted Critical
Publication of CN102939542B publication Critical patent/CN102939542B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/585—Calcitonins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/348—Urinary tract infections

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN201180014501.XA 2010-03-18 2011-03-15 用于泌尿道感染的分子标记物 Active CN102939542B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2010A000121 2010-03-18
IT000121A ITRM20100121A1 (it) 2010-03-18 2010-03-18 Marcatori molecolari per infezioni delle vie urinarie.
PCT/IB2011/051073 WO2011114287A2 (en) 2010-03-18 2011-03-15 Molecular markers for urinary tract infections

Publications (2)

Publication Number Publication Date
CN102939542A CN102939542A (zh) 2013-02-20
CN102939542B true CN102939542B (zh) 2015-07-08

Family

ID=42630320

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180014501.XA Active CN102939542B (zh) 2010-03-18 2011-03-15 用于泌尿道感染的分子标记物

Country Status (10)

Country Link
US (2) US8748195B2 (https=)
EP (1) EP2548031B1 (https=)
JP (1) JP5681219B2 (https=)
CN (1) CN102939542B (https=)
BR (1) BR112012023485B1 (https=)
ES (1) ES2484720T3 (https=)
IT (1) ITRM20100121A1 (https=)
RU (1) RU2611371C2 (https=)
WO (1) WO2011114287A2 (https=)
ZA (1) ZA201206633B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2592228C2 (ru) * 2014-04-10 2016-07-20 Владимир Игоревич Павлов Способ (варианты) и набор для диагностики инфекции мочевыводящих путей, способ лечения и определения предрасположенности к инфекции мочевыводящих путей
RU2679629C1 (ru) * 2018-07-05 2019-02-12 Антонина Ни Способ диагностики воспалительного процесса органов мочевыделительной системы у детей раннего возраста
RU2724186C1 (ru) * 2020-01-23 2020-06-22 Наталья Борисовна Гусева Способ лечения детей раннего возраста с рецидивирующей инфекцией мочевой системы
RU2766811C1 (ru) * 2021-06-22 2022-03-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ применения маркеров бактериального воспаления для диагностики инфекции мочевыводящих путей у детей первых трех лет жизни

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1751128A (zh) * 2002-12-24 2006-03-22 博适公司 用于区分性诊断的标志物和其应用方法
WO2007038758A2 (en) * 2005-09-28 2007-04-05 Becton, Dickinson And Company Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
EP2032992A1 (en) * 2007-02-28 2009-03-11 B.R.A.H.M.S. Aktiengesellschaft Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103123359B (zh) * 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
US8383332B2 (en) * 2009-10-13 2013-02-26 B.R.A.H.M.S. Gmbh Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack
EP2545379B1 (en) * 2010-03-08 2015-09-30 B.R.A.H.M.S GmbH Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
CN103096816B (zh) * 2010-05-04 2016-10-12 伊西康有限责任公司 用于产生自固位缝线的激光切割系统和方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1751128A (zh) * 2002-12-24 2006-03-22 博适公司 用于区分性诊断的标志物和其应用方法
WO2007038758A2 (en) * 2005-09-28 2007-04-05 Becton, Dickinson And Company Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
EP2032992A1 (en) * 2007-02-28 2009-03-11 B.R.A.H.M.S. Aktiengesellschaft Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
尿路感染患者的血清降钙素原水平研究;屈文烈等;《临床和实验医学杂志》;20081230;第7卷(第12期);11-12 *
血清降钙素原测定在感染性疾病中的临床意义;王延秋等;《中国综合临床》;20041030;第20卷(第10期);945-946 *
血清降钙素原测定在感染性疾病中的诊断价值;陈鸿恩等;《检验医学与临床》;20080114;第5卷(第01期);20-21 *
降钙素原测定在小儿尿路感染定位中的意义;张琦;《医学研究杂志》;20080315;第37卷(第03期);130-131 *

Also Published As

Publication number Publication date
US8748195B2 (en) 2014-06-10
CN102939542A (zh) 2013-02-20
HK1180392A1 (en) 2013-10-18
JP2013522618A (ja) 2013-06-13
ZA201206633B (en) 2015-04-29
WO2011114287A3 (en) 2011-12-15
RU2012144233A (ru) 2014-04-27
US20140242725A1 (en) 2014-08-28
ES2484720T3 (es) 2014-08-12
ITRM20100121A1 (it) 2011-09-19
BR112012023485A2 (pt) 2016-05-24
BR112012023485B1 (pt) 2020-03-17
WO2011114287A2 (en) 2011-09-22
RU2611371C2 (ru) 2017-02-21
US20130084650A1 (en) 2013-04-04
EP2548031A2 (en) 2013-01-23
EP2548031B1 (en) 2014-05-21
JP5681219B2 (ja) 2015-03-04

Similar Documents

Publication Publication Date Title
Luyt et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia
Horonenko et al. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report
Lee et al. The diagnosis of febrile urinary tract infection in children may be facilitated by urinary biomarkers
US11402393B2 (en) Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints
TW201643429A (zh) 前列腺抗原標準品及其用途
CN102939542B (zh) 用于泌尿道感染的分子标记物
US20140120174A1 (en) Methods of prognosis and diagnosis of sepsis
Kim et al. Evaluation of the clinical performance of an automated procalcitonin assay for the quantitative detection of bloodstream infection
US20130149725A1 (en) Methods and compositions for diagnosis of urosepsis and urinary tract infection
Hausfater et al. Procalcitonin measurement in routine emergency medicine practice: comparison between two immunoassays
CZ299992B6 (cs) Zpusob detekce patogenních organismu ve vzorcích stolice, slin, sekrekcního a bioptického materiálu
HK1180392B (en) Molecular markers for urinary tract infections
EP4533094A1 (en) Methods and systems for risk stratification and management of bladder cancer
CN113929748B (zh) 检测bace1酶活性的试剂盒及用途
CN102971630A (zh) 非酒精性脂肪性肝炎检测和/或鉴别用标记物、检测和/或鉴别非酒精性脂肪性肝炎的方法及用于它们的试剂盒
US20100304411A1 (en) Endogenous Morphine or a Naturally Occurring Metabolite Thereof as a Marker for Infection
Lee et al. Role of the urinary N-acetyl-beta-D-glucosaminidase/creatinine (NAG/Cr) ratio in discriminating between true and false pyuria in sterile urine bag specimens
CN112114138A (zh) 一种儿童肺炎支原体抗原的检测试剂盒及检测方法
JP2007520712A (ja) 患者サンプルにおけるＣｕ／Ｚｎスーパーオキシドジスムターゼ（Ｃｕ／ＺｎＳＯＤ）の濃度の選択的測定による敗血症の診断
JPH1132793A (ja) 尿路感染症の診断キット
Heilmann Laboratory Assessment of the Gastrointestinal Tract
Behera Laboratory Diagnosis of Human Melioidosis
McClerking 35. CALCITONIN AND PROCALCITONIN
Diggle et al. JAC-Antimicrobial Resistance
CN104246503A (zh) 肺炎球菌性肺炎的严重度判定方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1180392

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1180392

Country of ref document: HK